GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Alfresa Holdings Corp (GREY:ALFRY) » Definitions » Research & Development

Alfresa Holdings (Alfresa Holdings) Research & Development : $0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Alfresa Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Alfresa Holdings's Research & Development for the three months ended in Dec. 2023 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0 Mil.

Alfresa Holdings Research & Development Historical Data

The historical data trend for Alfresa Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alfresa Holdings Research & Development Chart

Alfresa Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Alfresa Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Alfresa Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alfresa Holdings  (GREY:ALFRY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Alfresa Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Alfresa Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Alfresa Holdings (Alfresa Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Alfresa Holdings Corp (GREY:ALFRY) » Definitions » Research & Development
Comparable Companies
TSE:9987 TSE:7459 TSE:8129 TSE:7476 TSE:3151 TSE:3183 SSE:3055 NGO:7488 TSE:7634 TSE:2689 MCK COR CAH HSIC SHSE:601607 HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE PDCO
Traded in Other Exchanges
2784:Japan
Address
1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004
Website
http://www.alfresa.com
Alfresa Holdings Corp is a holding company engaged in the distribution of drugs. The company is in the Ethical Pharmaceuticals Wholesaling Business, the Self-Medication Products Wholesaling Business, the Manufacturing Business, and the Medical-Related Business. It mainly provides distributes diagnostic reagents and medical devices/equipment, health foods, supplements and other products to drug stores and pharmacies. The firm manufactures and markets high-quality active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices.

Alfresa Holdings (Alfresa Holdings) Headlines

No Headlines